Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0005636
UniProt IDO14733
Primary gene name(s)MAP2K7
Synonym gene name(s)JNKK2, MEK7, MKK7, PRKMK7, SKK4
Protein nameDual specificity mitogen-activated protein kinase kinase 7
Protein functionDual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase, SAP/JNK signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by proinflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. {ECO:0000269|PubMed:9312068, ECO:0000269|PubMed:9372971, ECO:0000269|PubMed:9535930, ECO:0000269|Ref.5}.
Subcellular locationNucleus. Cytoplasm {ECO:0000250}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: O14733
Gene Ontology
(Biological Process)
Complete annatation
activation of JUN kinase activity [GO:0007257];
apoptotic process [GO:0006915];
Fc-epsilon receptor signaling pathway [GO:0038095];
JNK cascade [GO:0007254];
positive regulation of telomerase activity [GO:0051973];
positive regulation of telomere capping [GO:1904355];
positive regulation of telomere maintenance via telomerase [GO:0032212];
proteolysis in other organism [GO:0035897];
response to heat [GO:0009408];
response to osmotic stress [GO:0006970];
response to tumor necrosis factor [GO:0034612];
response to UV [GO:0009411];
signal transduction [GO:0007165];
stress-activated MAPK cascade [GO:0051403]
Gene Ontology
(Molecular Function)
Complete annatation
ATP binding [GO:0005524];
enzyme binding [GO:0019899];
JUN kinase kinase activity [GO:0008545];
magnesium ion binding [GO:0000287];
MAP kinase kinase activity [GO:0004708];
protein kinase binding [GO:0019901];
protein phosphatase binding [GO:0019903];
protein tyrosine kinase activity [GO:0004713];
receptor signaling protein serine/threonine kinase activity [GO:0004702]
Gene Ontology
(Cellular Component)
Complete annatation
cytoplasm [GO:0005737];
cytosol [GO:0005829];
nucleus [GO:0005634]
Protein-protein interaction111595
Phylogenetic treeO14733
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.05494890374879770.8677259957946270.912792160035176
AZA vs. DISU0.2501414038319490.3237254320107450.874052868015399
AZA vs. IL7-0.127454961694240.5088705345624930.999311006273513
AZA vs. SAHA-0.5141180109885620.05932323406844840.29798547314436
DISU vs. CD30.1818447283476120.6206618065595550.728589601736974
DISU vs. IL7-0.3872851879682640.1251345648186970.46371769042327
DISU vs. SAHA-0.7612139356445940.009703475506018360.101556305105002
DMSO vs. AZA0.07616613590033880.6507621702206051
DMSO vs. CD30.009460016671809230.9765746388256740.983889315448992
DMSO vs. DISU-0.1756524431173680.4723267690619990.897275884208221
DMSO vs. IL7-0.1963230900769240.2766764182164420.769860685669313
DMSO vs. SAHA-0.5950126834361690.01489362435057790.116181062415921
HIV vs. Mock in Activation0.3128393516871020.616415576429710.999983755607037
HIV vs. Mock in Latency0.02347920861230820.8872440091561470.999834320637052
IL7 vs. CD3-0.1777984235579850.5837588593200760.703108405782932
SAHA vs. CD3-0.5920168850420960.1054869742292880.181761799866839
SAHA vs. IL7-0.3890921622117130.1598923684516090.380035100980068
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) unknown
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.0973564 0.579686
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
1.132 0.913 1.022 0.999 0.923
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
2DYL X-ray 2.4Å A=101-405.
3WZU X-ray 3.0Å A=103-419.
4UX9 X-ray 2.3Å F/G/H/I=37-48.
5B2K X-ray 2.7Å A=103-419.
5B2L X-ray 2.1Å A=103-419.
5B2M X-ray 3.0Å A=103-419.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
Vpr induces phosphorylation of 24912525
Vpr activates 16243842

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa04010 MAPK signaling pathway - Homo sapiens (human)
hsa04012 ErbB signaling pathway - Homo sapiens (human)
hsa04141 Protein processing in endoplasmic reticulum - Homo sapiens (human)
hsa04380 Osteoclast differentiation - Homo sapiens (human)
hsa04530 Tight junction - Homo sapiens (human)
hsa04620 Toll-like receptor signaling pathway - Homo sapiens (human)
hsa04660 T cell receptor signaling pathway - Homo sapiens (human)
hsa04664 Fc epsilon RI signaling pathway - Homo sapiens (human)
hsa04668 TNF signaling pathway - Homo sapiens (human)
hsa04722 Neurotrophin signaling pathway - Homo sapiens (human)
hsa04912 GnRH signaling pathway - Homo sapiens (human)
hsa05164 Influenza A - Homo sapiens (human)
hsa05169 Epstein-Barr virus infection - Homo sapiens (human)